Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR

Biochemical and Biophysical Research Communications

Volumn 267, Issue 3, 2000, Pages 756-760

  Sumida, Akihiko ^a   Fukuen, Shuichi ^a   Yamamoto, Isamu ^a   Matsuda, Hideyasu ^a   Naohara, Masakazu ^a   Azuma, Junichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

CYPs mRNA; HepG2 cell; Induction; Reverse transcription competitive PCR

Indexed keywords

BETA ACTIN; CYTOCHROME P450 2C9; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DIMETHYLNITROSAMINE DEMETHYLASE; MESSENGER RNA; RIFAMPICIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034719327     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.2029     Document Type: Article

References (21)

1. Okey A. B. Pharmacol. Ther. 45:1990;241-298.
2. Kliewer S. A., Moore J. T., Wade L., Staudinger J. L., Watson M. A., Jones S. A., McKee D. D., Oliver B. B., Willson T. M., Zetterstrom R. H., Perimann T., Lehmann J. M. Cell. 92:1998;73-82.
3. Lehmann J. M., McKee D. D., Watson M. A., Willson T. M., Moore J. T., Kliewer S. A. J. Clin. Invest. 102:1998;1016-1032.
4. Daujat M., Peryt B., Lesca P., Fourtanie G., Domergue J., Maurel P. Biochem. Biophys. Res. Commun. 188:1992;820-825.
5. Donato M. T., Castell N. V., Gomez-Lechon M. J. Drug Metab. Dispos. 23:1995;553-558.
6. Strom S. C., Pisarov L. A., Dorko K., Thompson M. T., Schuetz J. D., Schuetz E. G. Methods Enzymol. 272:1996;388-401.
7. Li A. P., Maurel P., Gomez-Lechon M. J., Cheng L. C., Jurima-Romet M. Chem. Biol. Int. 107:1997;5-16.
8. Sumida A., Yamamoto I., Zhou Q., Morisaki T., Azuma J. Biol. Pharm. Bull. 22:1999;61-65.
9. Sumida A., Kinoshita K., Fukuda T., Matsuda H., Yamamoto I., Inaba T., Azuma J. Biochem. Biophys. Res. Commun. 262:1999;499-503.
10. Furuya H., Meyer U. A., Gelboin H. V., Gonzalez F. J. Mol. Pharmacol. 40:1991;375-382.
11. Andersen M. R., Farin F. M., Omiecinski C. J. DNA Cell Biol. 17:1998;231-238.
12. Chung I., Bresnich E. Arch. Biochem. Biophys. 314:1994;75-81.
13. Kim H., Reddy S., Novak R. F. Drug Metab. Dispos. 23:1995;818-824.
14. Bertz R. J., Granneman G. R. Clin. Pharmacokinet. 32:1997;210-258.
15. Ingelman-Sundberg M., Johansson I. J. Biol. Chem. 259:1984;6447-6458.
16. Ciummo P. E., Katz N. L. Am. Pharm. NS35:1995;41-51.
17. Acocella G. Clin. Pharmacokinet. 3:1978;108-127.
18. Boman G. Acta Pharmacol. et Toxicol. 36:1975;267-283.
19. Heimark L. D., Gibaldi M., Trager W. F. Clin. Pharmacol. Ther. 423:1987;385-394.
20. Bachmann K. A., Jauregui L. Xenobiotica. 23:1993;307-315.
21. Daniels N. J., Hunnisett A. G., Morris P. J. Lancet. II:1984;639.